pubmed-article:6983871 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:6983871 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:6983871 | lifeskim:mentions | umls-concept:C0024141 | lld:lifeskim |
pubmed-article:6983871 | lifeskim:mentions | umls-concept:C0032134 | lld:lifeskim |
pubmed-article:6983871 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:6983871 | pubmed:dateCreated | 1983-2-14 | lld:pubmed |
pubmed-article:6983871 | pubmed:abstractText | Plasmapheresis has been used as a supplementary method for the treatment of 11 cases of SLE (7 with lupus nephritis and 4 without renal changes). In 7 cases there was a marked improvement during the plasma exchanges which lasted from 2 months to 3 years of follow up. In one case the direct result was satisfactory but after 3 months there was a severe relapse and the patient died. In 3 cases (two without lupus nephritis) plasmapheresis was without any effect. We believe that plasmapheresis is chiefly indicated in severe cases with high levels of ds-DNA antibody titers. | lld:pubmed |
pubmed-article:6983871 | pubmed:language | eng | lld:pubmed |
pubmed-article:6983871 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6983871 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:6983871 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6983871 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:6983871 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:6983871 | pubmed:issn | 0004-069X | lld:pubmed |
pubmed-article:6983871 | pubmed:author | pubmed-author:Daszy?skiJJ | lld:pubmed |
pubmed-article:6983871 | pubmed:author | pubmed-author:BeutnerE HEH | lld:pubmed |
pubmed-article:6983871 | pubmed:author | pubmed-author:Jab?o?skaSS | lld:pubmed |
pubmed-article:6983871 | pubmed:author | pubmed-author:B?aszczykMM | lld:pubmed |
pubmed-article:6983871 | pubmed:author | pubmed-author:ChorzelskiTT | lld:pubmed |
pubmed-article:6983871 | pubmed:author | pubmed-author:GaczkowskiAA | lld:pubmed |
pubmed-article:6983871 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:6983871 | pubmed:volume | 29 | lld:pubmed |
pubmed-article:6983871 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:6983871 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:6983871 | pubmed:pagination | 769-72 | lld:pubmed |
pubmed-article:6983871 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:6983871 | pubmed:meshHeading | pubmed-meshheading:6983871-... | lld:pubmed |
pubmed-article:6983871 | pubmed:meshHeading | pubmed-meshheading:6983871-... | lld:pubmed |
pubmed-article:6983871 | pubmed:meshHeading | pubmed-meshheading:6983871-... | lld:pubmed |
pubmed-article:6983871 | pubmed:meshHeading | pubmed-meshheading:6983871-... | lld:pubmed |
pubmed-article:6983871 | pubmed:meshHeading | pubmed-meshheading:6983871-... | lld:pubmed |
pubmed-article:6983871 | pubmed:meshHeading | pubmed-meshheading:6983871-... | lld:pubmed |
pubmed-article:6983871 | pubmed:meshHeading | pubmed-meshheading:6983871-... | lld:pubmed |
pubmed-article:6983871 | pubmed:meshHeading | pubmed-meshheading:6983871-... | lld:pubmed |
pubmed-article:6983871 | pubmed:meshHeading | pubmed-meshheading:6983871-... | lld:pubmed |
pubmed-article:6983871 | pubmed:meshHeading | pubmed-meshheading:6983871-... | lld:pubmed |
pubmed-article:6983871 | pubmed:year | 1981 | lld:pubmed |
pubmed-article:6983871 | pubmed:articleTitle | Plasmapheresis in the treatment of systemic lupus erythematosus. | lld:pubmed |
pubmed-article:6983871 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:6983871 | pubmed:publicationType | Case Reports | lld:pubmed |